Targeted Next-Generation Sequencing for Suspected Inherited Neutropenia: Diagnostic Yield and Molecular Spectrum in a Large North American Cohort

Inherited neutropenia comprises a spectrum of rare hematological disorders defined by markedly low neutrophil counts from impaired myeloid precursor differentiation or function. Given their overlapping clinical presentations yet markedly different disease trajectories, treatment tolerance and response, and risk of transformation to myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML), these disorders require accurate molecular diagnosis. To address these complexities, our lab developed a 40-gene next-generation sequencing (NGS) panel targeting genes related to inherited neutropenias. Our panel also includes somatic variant analysis of CSF3R, RUNX1, and TP53, which have been implicated in leukemic transformation, to enhance diagnostic and prognostic assessment. We retrospectively reviewed 1145 patients with suspected inherited neutropenia who were referred from various institutions and underwent NGS testing at our institution between June 2014 and February 2023. A molecular diagnosis was made for 73 patients (6.4%). Among these, 64.4% had pathogenic/likely pathogenic variants in ELANE (47/73), followed by 8.2% in SBDS (6/73), 6.8% in G6PC3 (5/73), and 20.5% in other genes (15/73), including CSF3R , CXCR4 , SRP54 , GFI1 , JAGN1 , TAZ , TCN2 , VPS13B , and WAS. Somatic/likely somatic variants in CSF3R and TP53 were identified in two patients with corresponding pathogenic/likely pathogenic germline variants in ELANE and SBDS , respectively. Inconclusive findings were observed in 369 patients (32.2%), while 703 patients (61.4%) had negative findings. This study represents one of the largest North American cohorts of suspected inherited neutropenia and highlights the clinical utility of targeted NGS testing in improving diagnosis and potentially guiding patient management by providing molecular insights.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Immunology
Published
2026-11-19
DOI
https://doi.org/10.1007/s10875-026-02090-2
Primary Topic
Blood disorders and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Targeted Next-Generation Sequencing for Suspected Inherited Neutropenia: Diagnostic Yield and Molecular Spectrum in a Large North American Cohort

Kasiani C. Myers, James Denton, Ishaan Jindal, Yaning Wu et al.
Journal of Clinical Immunology
Blood disorders and treatments
article

Targeted Next-Generation Sequencing for Suspected Inherited Neutropenia: Diagnostic Yield and Molecular Spectrum in a Large North American Cohort

Kasiani C. Myers, James Denton, Ishaan Jindal, Yaning Wu, Qiaoning Guan, D. Brian Dawson, 张克俭, Wenying Zhang, Jie Liu, Jingfen Han
article en

Abstract

Inherited neutropenia comprises a spectrum of rare hematological disorders defined by markedly low neutrophil counts from impaired myeloid precursor differentiation or function. Given their overlapping clinical presentations yet markedly different disease trajectories, treatment tolerance and response, and risk of transformation to myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML), these disorders require accurate molecular diagnosis. To address these complexities, our lab developed a 40-gene next-generation sequencing (NGS) panel targeting genes related to inherited neutropenias. Our panel also includes somatic variant analysis of CSF3R, RUNX1, and TP53, which have been implicated in leukemic transformation, to enhance diagnostic and prognostic assessment. We retrospectively reviewed 1145 patients with suspected inherited neutropenia who were referred from various institutions and underwent NGS testing at our institution between June 2014 and February 2023. A molecular diagnosis was made for 73 patients (6.4%). Among these, 64.4% had pathogenic/likely pathogenic variants in ELANE (47/73), followed by 8.2% in SBDS (6/73), 6.8% in G6PC3 (5/73), and 20.5% in other genes (15/73), including CSF3R , CXCR4 , SRP54 , GFI1 , JAGN1 , TAZ , TCN2 , VPS13B , and WAS. Somatic/likely somatic variants in CSF3R and TP53 were identified in two patients with corresponding pathogenic/likely pathogenic germline variants in ELANE and SBDS , respectively. Inconclusive findings were observed in 369 patients (32.2%), while 703 patients (61.4%) had negative findings. This study represents one of the largest North American cohorts of suspected inherited neutropenia and highlights the clinical utility of targeted NGS testing in improving diagnosis and potentially guiding patient management by providing molecular insights.

Journal of Clinical Immunology
Cincinnati Children's Hospital Medical Center (US), University of Cincinnati (US)
Blood disorders and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon